Thornburg Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-111,667
Closed -$8.94M 193
2024
Q1
$8.94M Buy
111,667
+29,281
+36% +$2.61M 0.12% 122
2023
Q4
$9.02M Sell
82,386
-2,230
-3% -$231K 0.13% 111
2023
Q3
$8.53M Sell
84,616
-32
-0% -$3.68K 0.14% 106
2023
Q2
$11.5M Sell
84,648
-1,504
-2% -$184K 0.19% 91
2023
Q1
$8.95M Sell
86,152
-59,051
-41% -$5.71M 0.15% 109
2022
Q4
$12.9M Sell
145,203
-2,058
-1% -$171K 0.22% 76
2022
Q3
$11.8M Buy
147,261
+13,225
+10% +$1.25M 0.21% 85
2022
Q2
$12.8M Buy
134,036
+53,811
+67% +$6.46M 0.2% 90
2022
Q1
$11.9M Sell
80,225
-11,755
-13% -$1.64M 0.16% 109
2021
Q4
$13M Sell
91,980
-18,423
-17% -$2.61M 0.15% 118
2021
Q3
$14.4M Buy
+110,403
New +$14.4M 0.18% 106

Other funds holding CNMD

Thornburg Investment Management's CNMD Position: Q2 2024 in Review

Thornburg Investment Management sold out of CONMED (CNMD) in Q2 2024, closing a stake of 111,667 shares — an estimated $8.94M sold.

Thornburg Investment Management first reported a position in CNMD in Q3 2021 and held it in 11 quarters. The position peaked at $14.4M in Q3 2021. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Thornburg Investment Management reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • Thornburg Investment Management sold 111,667 CONMED shares in Q2 2024, an estimated $8.94M.
  • Thornburg Investment Management first reported a position in CONMED in Q3 2021 and held it in 11 quarters.
  • Thornburg Investment Management's CONMED position peaked at $14.4M in Q3 2021.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Thornburg Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.